MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria

Background: Long-term effects of gender-affirming hormonal therapy (GAHT) on cardiovascular risk factors and metabolic syndrome (MS) is currently unclear. Particularly, the effect of GAHT on cardiovascular outcomes in older individuals (>60 years) with gender dysphoria (GD) is unknown. The aim of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Mok, Mary, Pinkson, Sheila, Case, Emina, Bruder, Jan, Koops, Maureen, Tripathy, Devjit
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Reproductive Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550827/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars